Description
Ara-290 (Cibinetide) is a synthetic peptide derived from the structure of erythropoietin (EPO), engineered to retain tissue-protective signaling activity while lacking EPO’s blood-cell-stimulating (haematopoietic) effects.
In laboratory research, Ara-290 is examined for its selective activity at the innate repair receptor (IRR), a heterodimeric receptor complex distinct from the classical erythropoietin receptor responsible for red blood cell production.
Researchers studying Ara-290 focus on this receptor-selectivity as a model for isolating EPO’s tissue-protective, anti-inflammatory, and nerve-signaling-related effects from its haematological activity, offering a useful comparative tool in cytokine receptor research.
Its structural relationship to EPO also makes Ara-290 a frequently referenced compound in research examining structure-activity relationships within engineered cytokine-derived peptides.
Ara-290 is supplied strictly for laboratory research into innate repair receptor signaling and cytoprotective pathway research.
Reviews
There are no reviews yet.